180 Wealth Advisors, LLC Astrazeneca PLC Transaction History
180 Wealth Advisors, LLC
- $823 Million
- Q4 2025
A detailed history of 180 Wealth Advisors, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, 180 Wealth Advisors, LLC holds 7,816 shares of AZN stock, worth $698,750. This represents 0.08% of its overall portfolio holdings.
Number of Shares
7,816
Previous 7,374
5.99%
Holding current value
$698,750
Previous $565,000
23.54%
% of portfolio
0.08%
Previous 0.07%
Shares
29 transactions
Others Institutions Holding AZN
# of Institutions
1,501Shares Held
501MCall Options Held
5.59MPut Options Held
3.18M-
Price T Rowe Associates Inc Baltimore, MD49.1MShares$4.39 Billion0.4% of portfolio
-
Primecap Management CO Pasadena, CA39.9MShares$3.56 Billion2.42% of portfolio
-
Bank Of America Corp Charlotte, NC32.6MShares$2.92 Billion0.18% of portfolio
-
Wellington Management Group LLP Boston, MA32.3MShares$2.89 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA25.1MShares$2.24 Billion0.33% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $277B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...